XML 22 R6.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Comprehensive Income - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Statement of Comprehensive Income [Abstract]      
Net income $ 230,064 $ 1,241,201 $ 1,701,954
Changes in other comprehensive income/(loss):      
Reclassification of loss on interest rate swaps 0 0 4,066
Unrealized gains on available for sale debt securities 24,000 11,600 83,120
Reclassification of unrealized gains on available for sale debt securities (53,432) (50,896) (20,551)
Other comprehensive (loss)/income (29,432) (39,296) 66,635
Comprehensive income 200,632 1,201,905 1,768,589
Comprehensive income attributable to non-controlling interests 175,418 604,323 739,787
Comprehensive income attributable to Royalty Pharma plc $ 25,214 $ 597,582 $ 1,028,802